https://www.selleckchem.com/pr....oducts/gc7-sulfate.h
Findings from randomized clinical trials mayhave limited generalizability to patients treated in routine clinical practice. This study examined the effectiveness of first-line palbociclib plus letrozole versus letrozole alone on survival outcomes in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor-negative (HER2-) metastatic breast cancer (MBC) treated in routine clinical practice in the USA. This was a retrospective observational analysis of electronic health records within the Flatiron Health An
Like
Comment
Share
